3SBio Inc. Schedules Unaudited Second Quarter 2011 Results

SHENYANG, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) (“3SBio” or “the Company”), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited second quarter 2011 results after the NASDAQ stock market closes on Monday, August 15, 2011 at 8:00pm (US Eastern).

Following the earnings announcement, 3SBio’s senior management will host a conference call on Tuesday, August 16, 2011 at 5:00am (US Pacific) / 8:00am (US Eastern) / 8:00pm (Beijing) to discuss its unaudited second quarter 2011 results and recent business activity. The conference call may be accessed using the dial-in numbers below:

A telephone replay will be available two hours after the call until August 23, 2011 at:

Webcast

A live webcast of the conference will be available on the investor relations section of 3SBio’s website at www.3sbio.com and at http://tinyurl.com/3sbio2Q11.

A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol “SSRX”. Please see www.3SBio.com for more information.

SOURCE 3SBio Inc.